Clinical trials
Ulcer trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Northland Biotech. Co., Ltd. | 3 |
| Sun Yat-sen University | 2 |
| Allife Medical Science and Technology Co., Ltd. | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Chinese University of Hong Kong | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| Hangzhou Endonom Medtech Co., Ltd. | 1 |
| Peking Union Medical College | 1 |
| Second Affiliated Hospital of Wenzhou Medical University | 1 |
| West China Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ulcer | 13 |
| Chronic Limb-Threatening Ischemia | 4 |
| Peripheral Vascular Diseases | 4 |
| Stomatitis | 4 |
| Arterial Occlusive Diseases | 3 |
| Ischemia | 3 |
| Aneurysm | 1 |
| Aneurysm, Aortic Arch | 1 |
| Aneurysm, False | 1 |
| Aortic Dissection | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.